- Home
- Services
- united kingdom
- clinical linked data
Show results for
Refine by
Clinical Linked Data Services In United Kingdom
11 services found
Manufactured by:Exscientia based inOxford, UNITED KINGDOM
Drug design is engineering at the molecular scale. Every position of every atom and every bond determines the future success of a ...
by:Heartbeat Medical based inBerlin, GERMANY
Implementing outcome measurement in routine clinical practice is an ongoing and interactive process. Since 2014, Heartbeat Medical has worked with leading healthcare organizations to make digital PRO collection part of their day-to-day operations. So far, together with our partners, we have made the monitoring of treatment outcomes a reality for more than 250,000 patients. ...
by:Heartbeat Medical based inBerlin, GERMANY
Healthcare providers are increasingly shifting from product buying towards solution procurement to mitigate risks associated with the roll-out of innovative products. Limitations of traditional clinical study data have accelerated the need for Real-World Data to demonstrate real-world impact and superior clinical value. Heartbeat Medical provides an independent outcome measurement platform to ...
by:Clinisys, Inc. based inTucson, ARIZONA (USA)
Streamlining communications between healthcare providers and diagnostics. A solution that bridges the divides in healthcare to provide you with an electronic request and result consultation channel that supports multiple diagnostic specialties, including pathology, radiology, cardiology, and ...
by:Physiomics Plc based inOxford, UNITED KINGDOM
Pharmacokinetic (PK) & Pharmacodynamic (PD) modelling is often an integral component in the drug development process. PK involves studying the movement of a certain drug dose in the body. PD involves studying how a certain drug dose affects the body. Collectively, PK/PD modelling uses mathematical models to simulate the expected effect of a certain drug dose over ...
by:OracleBio based inGlasgow, UNITED KINGDOM
Good Clinical Practice (GCP) is an internationally recognised ethical and scientific standard for designing, recording and reporting trials that involve the participation of human subjects. Studies conducted in accordance with this standard provides assurance that the rights, safety and wellbeing of trial subjects are protected and that clinical-trial data are credible (EMA Website). For ...
by:OracleBio based inGlasgow, UNITED KINGDOM
Helping you maximise the value of your clinical samples with Quantitative Image Analysis. At OracleBio, we have extensive experience in performing quantitative analysis of tissue samples in clinical research. Our team of expert image analysis scientists performs analysis in a detailed and unbiased manner across digital whole slide tissue images to ensure data is fully representative of the ...
Manufactured by:Exscientia based inOxford, UNITED KINGDOM
Only with continual feedback between experiment and prediction can machine learning models be refined and deliver against complex therapeutic ...
by:Almac Group based inCraigavon, UNITED KINGDOM
Almac Diagnostic Services can also help Biopharma clients validate reliable Pharmacodynamic (PD) Biomarker assays that can help provide invaluable guidance within their drug development programmes. Almac also has extensive experience in the discovery of clinically applicable biomarkers, through our own range of Almac proprietary assays (DDIR, Prostate Dx, ColDx, Angio, and EMT) and through ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Prostate cancer is the most common type of cancer (aside from skin) in American men with 13 out of every 100 being diagnosed with the disease during their lifetime.1,2Prostate-specific membrane antigen (PSMA) is a transmembrane protein that is expressed in high levels in prostate cancer cells. Due to its location on the cell surface, PSMA is a popular target for imaging to identify the presence ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Radiopharmaceutical therapies represent an effective way to treat solid cancers by using tumor targeting small molecules, peptides or biologics to deliver a cytotoxic payload that induces DNA damage in tumor cells, while limiting damage to normal and healthy tissue. Streamlined development, evaluation and clinical translation of radiopharmaceuticals requires a partner that has extensive ...